Zhen Jin

Zhen Jin


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2017 in Analytical Chemistry
Verified
Journal Article
Closed access
JZJing Zhang
Jing Zhang
ZJZhen Jin
Zhen Jin
XHXiao-Xiao Hu
Xiao-Xiao Hu
HMHong-Min Meng
Hong-Min Meng
JLJin Li
Jin Li
LFLili Feng
Lili Feng

1 October 2020 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ZZZhe Zhang
Zhe Zhang
KLKang Li
Kang Li
GZGuang-Yu Zhang
Guang-Yu Zhang
YTYouzhi Tang
Youzhi Tang
ZJZhen Jin
Zhen Jin

1 July 2021 in Bioorganic Chemistry
Verified
Journal Article
Closed access
JLJie Liu
Jie Liu
GZGuang-Yu Zhang
Guang-Yu Zhang
ZZZhe Zhang
Zhe Zhang
BLBo Li
Bo Li
FCFei Chai
Fei Chai
YTYouzhi Tang
Youzhi Tang

17 February 2020 in Molecules
Verified
Journal Article
Open access
PDF file
XZXiangyi Zuo
Xiangyi Zuo
XFXi Fang
Xi Fang
ZZZhaosheng Zhang
Zhaosheng Zhang
ZJZhen Jin
Zhen Jin
GXGaolei Xi
Gaolei Xi
YTYouzhi Tang
Youzhi Tang
A new pleuromutilin derivative, 22-(2-amino-phenylsulfanyl)-22-deoxypleuromutilin (amphenmulin), has been synthesized and proved excellent in vitro and in vivo efficacy than that of tiamulin against methicillin-resistant Staphylococcus aureus (MRSA), suggesting this compound may lead to a promising antibacterial agent to treat MRSA infections. In this study, the effectiveness and safety of amphenmulin were further investigated. Amphenmulin showed excellent antibacterial activity against MRSA (minimal inhibitory concentration = 0.0156~8 µg/mL) and performed time-dependent growth inhibition and a concentration-dependent postantibiotic effect (PAE). Acute oral toxicity test in mice showed that amphenmulin was a practical non-toxic drug and possessed high security as a new drug with the 50% lethal dose (LD50) above 5000 mg/kg. The pharmacokinetic properties of amphenmulin were then measured. After intravenous administration, the elimination half-life (T1/2), total body clearance (Clβ), and area under curve to infinite time (AUC0→∞) were 1.92 ± 0.28 h, 0.82 ± 0.09 L/h/kg, and 12.23 ± 1.35 μg·h/mL, respectively. After intraperitoneal administration, the T1/2, Clβ/F and AUC0→∞ were 2.64 ± 0.72 h, 4.08 ± 1.14 L/h/kg, and 2.52 ± 0.81 μg·h/mL, respectively, while for the oral route were 2.91 ± 0.81 h, 6.31 ± 2.26 L/h/kg, 1.67 ± 0.66 μg·h/mL, respectively. Furthermore, we evaluated the antimicrobial activity of amphenmulin in an experimental model of MRSA wound infection. Amphenmulin enhanced wound closure and promoted the healing of wound, which inhibited MRSA bacterial counts in the wound and decreased serum levels of the pro-inflammatory cytokines TNF-α, IL-6, and MCP-1.

10 May 2022 in Bioorganic Chemistry
Verified
Journal Article
Closed access
FCFei Chai
Fei Chai
JWJun Wang
Jun Wang
KZKe-Xin Zhou
Ke-Xin Zhou
SWShou-Kai Wang
Shou-Kai Wang
YLYa-Hong Liu
Ya-Hong Liu
YTYouzhi Tang
Youzhi Tang

29 January 2022 in Molecules
Verified
Journal Article
Open access
PDF file
HFHan-Qing Fang
Han-Qing Fang
JZJie Zeng
Jie Zeng
SWShou-Kai Wang
Shou-Kai Wang
XWXiao Wang
Xiao Wang
Fang ChenFang Chen
Fang Chen
YTYouzhi Tang
Youzhi Tang
A series of novel pleuromutilin derivatives containing nitrogen groups on the side chain of C14 were synthesized under mild conditions. Most of the synthesized derivatives displayed potent antibacterial activities. Compound 9 was found to be the most active antibacterial derivative against MRSA (MIC = 0.06 μg/mL). Furthermore, the result of time-kill curves showed that compound 9 had a certain inhibitory effect against MRSA in vitro. Moreover, according to a surface plasmon resonance (SPR) study, compound 9 (KD = 1.77 × 10−8 M) showed stronger affinity to the 50S ribosome than tiamulin (KD = 2.50 × 10−8 M). The antibacterial activity of compound 9 was further evaluated in an MRSA-infected murine thigh model. Compared to the negative control group, tiamulin reduced MRSA load (~0.7 log10 CFU/mL), and compound 9 performed a treatment effect (~1.3 log10 CFU/mL). In addition, compound 9 was evaluated in CYP450 inhibition assay and showed only moderate in vitro CYP3A4 inhibition (IC50 = 2.92 μg/mL).